Average Co-Inventor Count = 6.26
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Biotechnology Ltd (11 from 93 patents)
2. Abbvie Inc. (2 from 822 patents)
3. Abbott Laboratories Corporation (1 from 4,177 patents)
4. Abb Vie Deutschland Gmbh & Co. Kg (1 from 150 patents)
14 patents:
1. 9512216 - Use of TNFα inhibitor
2. 9499615 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease
3. 9187559 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease
4. 9090689 - Use of TNFα inhibitor for treatment of psoriasis
5. 9085620 - Use of TNFα inhibitor for treatment of psoriatic arthritis
6. 9061005 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease
7. 9051368 - Methods for treating psoriasis by administering an antibody which binds an epitope of the p40 subunit of IL-12 and/or IL-23
8. 8986693 - Use of TNFα inhibitor for treatment of psoriasis
9. 8961973 - Multiple-variable dose regimen for treating TNFα-related disorders
10. 8961974 - Multiple-variable dose regimen for treating TNFα-related disorders
11. 8906373 - Use of TNF-alpha inhibitor for treatment of psoriasis
12. 8889136 - Multiple-variable dose regimen for treating TNFα-related disorders
13. 8557239 - Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23
14. 7776331 - Methods of treating plaque psoriasis